The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[4-(4-indolo[1,2-c]quinazolin-6-ylphenoxy)phenyl]-indolo[1,2-c]quinazoline ID: ALA1076885
PubChem CID: 45276791
Max Phase: Preclinical
Molecular Formula: C42H26N4O
Molecular Weight: 602.70
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(c1)cc1c3ccccc3nc(-c3ccc(Oc4ccc(-c5nc6ccccc6c6cc7ccccc7n56)cc4)cc3)n21
Standard InChI: InChI=1S/C42H26N4O/c1-7-15-37-29(9-1)25-39-33-11-3-5-13-35(33)43-41(45(37)39)27-17-21-31(22-18-27)47-32-23-19-28(20-24-32)42-44-36-14-6-4-12-34(36)40-26-30-10-2-8-16-38(30)46(40)42/h1-26H
Standard InChI Key: CDQWZUMQTPEBPC-UHFFFAOYSA-N
Molfile:
RDKit 2D
47 56 0 0 0 0 0 0 0 0999 V2000
3.0786 -19.1151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0786 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7909 -20.3546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5073 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5073 -19.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2195 -18.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2195 -17.8797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5073 -17.4651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7909 -17.8797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7909 -18.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1165 -20.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7806 -21.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1165 -21.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6341 -22.6660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8119 -22.5775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4760 -21.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9624 -21.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3623 -20.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3623 -21.1796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6458 -21.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9295 -21.1796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9295 -20.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6458 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2172 -21.5900 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4950 -21.1796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2073 -21.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9236 -21.1796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9236 -20.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2073 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4950 -20.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3564 -20.3546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6400 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6400 -19.1151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3564 -18.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0686 -19.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7850 -18.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4972 -19.1151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4972 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7850 -20.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0686 -19.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1849 -17.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3626 -17.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8761 -17.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0538 -17.2282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7221 -17.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2044 -18.6450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0267 -18.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
3 17 1 0
4 11 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
24 25 1 0
31 32 2 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
31 40 1 0
35 40 2 0
41 42 1 0
42 43 1 0
43 44 2 0
44 45 1 0
45 46 2 0
46 47 1 0
42 47 2 0
33 47 1 0
34 41 2 0
28 32 1 0
21 24 1 0
2 18 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 602.70Molecular Weight (Monoisotopic): 602.2107AlogP: 10.72#Rotatable Bonds: 4Polar Surface Area: 43.83Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 1.47CX LogP: 9.19CX LogD: 9.19Aromatic Rings: 10Heavy Atoms: 47QED Weighted: 0.20Np Likeness Score: -0.38
References 1. Rohini R, Muralidhar Reddy P, Shanker K, Hu A, Ravinder V.. (2010) Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines., 45 (3): [PMID:20005020 ] [10.1016/j.ejmech.2009.11.038 ]